By Andrea Chang, Los Angeles Times After weeks of talks, Pfizer and Allergan are set to approve a blockbuster merger worth $150 billion. The companies' boards of directors were reportedly expected to approve the deal Sunday, with details probably announced Monday, according to the Wall Street Journal. If completed, it would cap a remarkable consolidation wave roiling the U.S. health care industry and create the world's biggest drug maker by sales. A deal between Pfizer and Botox maker Allergan would be the largest corporate merger this year. As of Friday's close, Pfizer had a market cap of $199 billion; Allergan was at $123 billion. | Nov. 22, 2015 7:29 p.m. UW 74, VCU 73 By...
↧